Katsura Y, Tomishi T, Inoue Y, Sakane K, Matsumoto Y, Ishikawa H, Takasugi H
New Drug Research Laboratories, Fujisawa Pharmaceutical Company, Ltd., Osaka, Japan.
J Med Chem. 1997 Aug 1;40(16):2462-5. doi: 10.1021/jm970407n.
A series of 2-(alkylguanidino)-4-[5-(acetamidomethyl)furan-2-yl]thiazoles and related compounds were synthesized and evaluated for antimicrobial activity against Helicobacter pylori, inhibitory effect on gastric acid secretion, and histamine H2-receptor antagonist activity. Introduction of alkyl substituents on the guanidino moiety resulted in a significant increase in antimicrobial activity, which was associated with the alkyl chain length. Of the compounds obtained, the n-hexylguanidino derivative 13 demonstrated a 250-fold improvement in activity (MIC = 0.11 micrograms/mL) over the unsubstituted guanidino derivative 7. Alkyl-substituted guanidino derivatives also displayed gastric antisecretion and H2-antagonist activities. However, a simple correlation between the alkyl chain length and the activities was not found in these assays. Replacement of the guanidine with other bioisosteric groups (thiourea, urea, or (dimethylamino)methyl) resulted in loss of all activities tested. Thus the guanidino moiety was found to be essential for activity in this series of compounds.
合成了一系列2-(烷基胍基)-4-[5-(乙酰氨基甲基)呋喃-2-基]噻唑及其相关化合物,并对其抗幽门螺杆菌的抗菌活性、胃酸分泌抑制作用和组胺H2受体拮抗剂活性进行了评估。在胍基部分引入烷基取代基导致抗菌活性显著增加,这与烷基链长度有关。在所得到的化合物中,正己基胍基衍生物13的活性(MIC = 0.11微克/毫升)比未取代的胍基衍生物7提高了250倍。烷基取代的胍基衍生物也表现出胃分泌抑制和H2拮抗剂活性。然而,在这些试验中未发现烷基链长度与活性之间存在简单的相关性。用其他生物电子等排体基团(硫脲、脲或(二甲氨基)甲基)取代胍会导致所有测试活性丧失。因此,发现胍基部分对于该系列化合物的活性至关重要。